A space for sharing and discussing news related to global current events, technology, and society.
69423 Members
We'll be adding more communities soon!
© 2020 Relevant Protocols Inc.
A space for sharing and discussing news related to global current events, technology, and society.
69423 Members
We'll be adding more communities soon!
© 2020 Relevant Protocols Inc.
Relevant
Hot
New
Spam
Relevant
Hot
New
Spam
0
357
0
357
"The authorization of the treatment, bebtelovimab, means that the United States now has four drugs available for high-risk Covid patients early in the course of their illness that have been found to neutralize the Omicron variant. While _...Read More_
"The authorization of the treatment, bebtelovimab, means that the United States now has four drugs available for high-risk Covid patients early in the course of their illness that have been found to neutralize the Omicron variant. While _...Read More_
0
130
0
130
[https://www.nytimes.com/2022/02/11/world/monoclonal-antibody-treatment-emergency-authorization.html](https://www.nytimes.com/2022/02/11/world/monoclonal-antibody-treatment-emergency-authorization.html) >"The federal government has ordered 600,000 doses of the treatment, which is meant for high-risk Covid patients early in their illness."
[https://www.nytimes.com/2022/02/11/world/monoclonal-antibody-treatment-emergency-authorization.html](https://www.nytimes.com/2022/02/11/world/monoclonal-antibody-treatment-emergency-authorization.html) >"The federal government has ordered 600,000 doses of the treatment, which is meant for high-risk Covid patients early in their illness."
0
165
0
165
>"The federal government has ordered 600,000 doses of the treatment, which is meant for high-risk Covid patients early in their _...Read More_
>"The federal government has ordered 600,000 doses of the treatment, which is meant for high-risk Covid patients early in their _...Read More_
0
32.2
0
32.2
Participants with the disease still declined, but much more slowly than those receiving a placebo, investigators say.
Participants with the disease still declined, but much more slowly than those receiving a placebo, investigators say.
0
9.9
0
9.9
"Eli Lilly & Co.’s antibody therapy was granted an emergency-use authorization by U.S. drug regulators for treating _...Read More_
"Eli Lilly & Co.’s antibody therapy was granted an emergency-use authorization by U.S. drug regulators for treating _...Read More_